These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29524157)

  • 21. Simultaneous quantification of tramadol and O-desmethyltramadol in hair samples by gas chromatography-electron impact/mass spectrometry.
    Pinho S; Oliveira A; Costa I; Gouveia CA; Carvalho F; Moreira RF; Dinis-Oliveira RJ
    Biomed Chromatogr; 2013 Aug; 27(8):1003-11. PubMed ID: 23519701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol.
    Fonseca S; Amorim A; Costa HA; Franco J; Porto MJ; Santos JC; Dias M
    Forensic Sci Int; 2016 Aug; 265():153-9. PubMed ID: 26926096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an analytical method for simultaneous detection of psychotropic phenylalkylamines in hair by LC-MS/MS with a multi-mode reversed-phase column using pH gradient elution.
    Choi H; Kim S; Ahn S; Chang H; Lee S; Lee Y
    Forensic Sci Int; 2016 Feb; 259():69-76. PubMed ID: 26760907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood.
    Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A
    Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enantiomeric determination of tramadol and O-desmethyltramadol in human plasma by fast liquid chromatographic technique coupled with mass spectrometric detection.
    Chytil L; Matousková O; Cerná O; Pokorná P; Vobruba V; Perlík F; Slanar O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):481-6. PubMed ID: 20018572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
    Halling J; Weihe P; Brosen K
    Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An LC-MS/MS method for the simultaneous determination of 15 antipsychotics and two metabolites in hair and its application to rat hair.
    Sim J; Kim E; Yang W; Woo S; In S
    Forensic Sci Int; 2017 May; 274():91-98. PubMed ID: 28111036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural elucidation of tramadol, its derivatives, and metabolites using chemical derivatization and liquid chromatography-high-resolution tandem mass spectrometry.
    Shamai Yamin T; Shifrovitch A; Madmon M; Prihed H; Weissberg A
    Rapid Commun Mass Spectrom; 2024 Oct; 38(20):e9881. PubMed ID: 39157950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hair testing in clinical setting: Simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS.
    Licata M; Rustichelli C; Palazzoli F; Ferrari A; Baraldi C; Vandelli D; Verri P; Marchesi F; Silingardi E
    J Pharm Biomed Anal; 2016 Jul; 126():14-25. PubMed ID: 27136283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
    Suzuki K; Naito T; Tanaka H; Yamada Y; Itoh K; Kawakami J
    Ther Drug Monit; 2020 Jun; 42(3):503-511. PubMed ID: 31613803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics.
    de Moraes NV; Lauretti GR; Napolitano MN; Santos NR; Godoy AL; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):140-7. PubMed ID: 22173007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of cocaine and metabolites in hair by column-switching LC-MS-MS analysis.
    Alves MN; Zanchetti G; Piccinotti A; Tameni S; De Martinis BS; Polettini A
    Anal Bioanal Chem; 2013 Jul; 405(19):6299-306. PubMed ID: 23702902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.
    Tzvetkov MV; Saadatmand AR; Lötsch J; Tegeder I; Stingl JC; Brockmöller J
    Clin Pharmacol Ther; 2011 Jul; 90(1):143-50. PubMed ID: 21562485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of tramadol in hair using solid phase extraction and GC-MS.
    Hadidi KA; Almasad JK; Al-Nsour T; Abu-Ragheib S
    Forensic Sci Int; 2003 Aug; 135(2):129-36. PubMed ID: 12927414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An LC-MS/MS method for the determination of five erectile dysfunction drugs and their selected metabolites in hair.
    Lee S; Choi B; Kim J; In S; Baeck S; Oh SM; Chung KH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():1-10. PubMed ID: 25531864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques.
    De Leo M; Giorgi M; Saccomanni G; Manera C; Braca A
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):228-36. PubMed ID: 19072864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.
    Arafa MH; Atteia HH
    Toxicol Appl Pharmacol; 2018 May; 346():37-44. PubMed ID: 29555325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
    Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
    Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
    Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
    Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.